Taurine supplementation decreases fat accumulation by suppressing FAS and enhancing ATGL through the ATGL pathway

Document Type : Original Article

Authors

1 College of Biochemical Engineering, Beijing Union University, Beijing, China

2 Beijing Key Laboratory of Bioactive Substances and Functional Foods, Beijing Union University, Beijing, China

10.22038/ijbms.2024.76625.16590

Abstract

Objective(s): Obesity leads to severe health issues like cardiovascular disease. Natural substances with anti-obesity properties are gaining attention. This study investigates the impact of taurine on lipid levels in rats fed a high-fat diet.
Materials and Methods: The SD rats were fed a high-fat diet and treated with or without taurine for 21 weeks. Taurine was added to their drinking water, and an adipose triglyceride lipase (ATGL) inhibitor was injected for one week. The study evaluated the impact of taurine supplementation on the rats’ body weight, Lee index, body fat content, serum levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), fatty acid synthase (FAS), ATGL, and peroxisome proliferator-activated receptor α (PPARα) in the liver. Fat accumulation in the liver and aortic arch was assessed through histopathological observations.
Results: The study found that taurine reduced body weight, body fat, serum TG, TC, LDL-C levels, and lipid deposition in the liver and aortic arch while increasing serum HDL-C levels. Taurine intake also increased FAS and ATGL expression in the liver. Interestingly, the ATGL inhibitor atglistatin did not affect FAS and ATGL expression in the presence of taurine.
Conclusion: Taurine can reduce fat deposition caused by a high-fat diet in SD rats by decreasing FAS content and increasing ATGL content. However, taurine does not fully regulate FAS and ATGL expression through the ATGL pathway.

Keywords

Main Subjects


1. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
2.    Ibrahim MA, Eraqi MM, Alfaiz FA. Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats. Heliyon 2020; 6:1-9.
3.    Di Ciaula A, Garruti G, Lunardi Baccetto R, Molina-Molina E, Bonfrate L, Wang DQ. Bile acid physiology. Ann Hepatol 2017; 16:4-14. 
4.    Qaradakhi T, Gadanec LK, McSweeney KR, Abraham JR, Apostolopoulos V, Zulli A. The anti-inflammatory effect of taurine on cardiovascular disease. Nutrients 2020; 12:2847-2870. 
5.    Yang L, Qiu T, Yao X, Jiang L, Wei S, Pei P, et al. Taurine protects against arsenic trioxide-induced insulin resistance via ROS-Autophagy pathway in skeletal muscle. Int J Biochem Cell Biol 2019; 112:50-60. 
6.    Wen C, Li F, Zhang L, Duan Y, Guo Q, Wang W, et al. Taurine is involved in energy metabolism in muscles, adipose tissue, and the liver. Mol Nutr Food Res 2019; 63:1-28.
7.    Kim KS, Jang MJ, Fang S, Yoon SG, Kim IY, Seong JK, et al. Anti-obesity effect of taurine through inhibition of adipogenesis in white fat tissue but not in brown fat tissue in a high-fat diet-induced obese mouse model. Amino Acids 2019; 51:245-254. 
8.    Kim KS, Doss HM, Kim HJ, Yang HI. Taurine stimulates thermoregulatory genes in brown fat tissue and muscle without an influence on inguinal white fat tissue in a high-fat diet-induced obese mouse model. Foods 2020; 9:688-702. 
9.    Guo J, Gao Y, Cao X, Zhang J, Chen W. Cholesterol-lowing effect of taurine in HepG2 cell. Lipids Health Dis 2017; 16:56-63. 
10.    Wang Z, Ohata Y, Watanabe Y, Yuan Y, Yoshii Y, Kondo Y, et al. Taurine improves lipid metabolism and increases resistance to oxidative stress. J Nutr Sci Vitaminol 2020; 66:347-356. 
11.    Murakami S, Kondo Y, Nagate T. Effects of long-term treatment with taurine in mice fed a high-fat diet: improvement in cholesterol metabolism and vascular lipid accumulation by taurine. Adv Exp Med Biol 2000; 483:177-186. 
12.    Maleki V, Alizadeh M, Esmaeili F, Mahdavi R. The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Amino Acids 2020; 52:905-914. 
13.    . Yanagita T, Han SY, Hu Y, Nagao K, Kitajima H, Murakami S. Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells. Lipids Health Dis 2008; 7:38-44. 
14.    Kim HM, Do CH, Lee DH. Characterization of taurine as anti-obesity agent in C. elegans. J Biomed Sci 2010; 17:33-39. 
15.    Kang YJ, Choi MJ. Liver antioxidant enzyme activities increase after taurine in ovariectomized rats. Adv Exp Med Biol 2017; 975:1071-1080. 
16.    Zhang J, Miao G, Cao JM, Zhou HT, Niu YL, Zhang Y, et al. Effects of aerobic exercise combined with chlorella pyrenoidos of disintegrated cell wall on some indicators of lipid metabolism in rats with high-fat diet. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2018; 34:445-449. 
17.    Kim KS, Doss HM, Kim HJ, Yang HI. Taurine stimulates thermoregulatory genes in brown fat tissue and muscle without an influence on inguinal white fat tissue in a high-fat diet-induced obese mouse model. Foods 2020; 9:688-703. 
18.    Tang R, Yang Q, Lin S, Feng Y, Yang J, Lv Q, et al. Preventive or curative administration of taurine regulates lipid metabolism in the liver of rats with alcoholic liver disease. Adv Exp Med Biol 2019; 1155:119-131. 
19.    Zhao D, Lv Q, Yang J, Wu G, Liu M, Yang Q, et al. Taurine improves lipid metabolism and skeletal muscle sensitivity to insulin in rats fed with high sugar and high fat diet. Adv Exp Med Biol 2019; 1155:133-146.
20.    Matsushima Y, Sekine T, Kondo Y, Sakurai T, Kameo K, Tachibana M, et al. Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidemic mice. Clin Exp Pharmacol Physiol 2003; 30:295-299. 
21.    Dong Y, Li X, Liu Y, Gao J, Tao J. The molecular targets of taurine confer anti-hyperlipidemic effects. Life Sci 2021; 278:1-8. 
22.    Jia F, Hu X, Kimura T, Tanaka N. Impact of dietary fat on the progression of liver fibrosis: lessons from animal and cell studies. Int J Mol Sci 2021; 22:10303-10318. 
23.    Chen B, Zhou H, Zhao W, Zhou W, Yuan Q, Yang G. Effects of aqueous extract of Portulaca oleracea L. on oxidative stress and liver, spleen leptin, PARα and FAS mRNA expression in high-fat diet induced mice. Mol Biol Rep 2012; 39:7981-7988.
24.    Morsy MD, Aboonq MS, ALsleem MA, Abusham AA. Taurine prevents high-fat diet-induced-hepatic steatosis in rats by direct inhibition of hepatic sterol regulatory element-binding proteins and activation of AMPK. Clin Exp Pharmacol Physiol 2020; 48:72-85.
25.    Lu Z, He X, Ma B, Zhang L, Li J, Jiang Y, et al. Dietary taurine supplementation decreases fat synthesis by suppressing the liver X receptor α pathway and alleviates lipid accumulation in the liver of chronic heat-stressed broilers. J Sci Food Agric 2019; 99:5631-5637. 
26.    Alves-Bezerra M, Cohen DE. Triglyceride metabolism in the Liver. Compr Physiol 2017; 8:1-8.
27.    Sathyanarayan A, Mashek MT, Mashek DG. ATGL promotes autophagy/lipophagy via SIRT1 to control hepatic lipid droplet catabolism. Cell Rep 2017; 19:1-9. 
28.    Cerk IK, Wechselberger L, Oberer M. Adipose triglyceride lipase regulation: an overview. Curr Protein Pept Sci 2018; 19:221-233. 
29.    Steinberg GR, Kemp BE, Watt MJ. Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab 2007; 293:958-964. 
30.    Liu X, Liang Y, Song R, Yang G, Han J, Lan Y, et al. Long noncoding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation. Mol Cancer 2018; 17:90-108.